Ketamine evoked disruption of entorhinal and hippocampal spatial maps.
Francis Kei MasudaEmily A Aery JonesYanjun SunLisa M GiocomoPublished in: Nature communications (2023)
Ketamine, a rapid-acting anesthetic and acute antidepressant, carries undesirable spatial cognition side effects including out-of-body experiences and spatial memory impairments. The neural substrates that underlie these alterations in spatial cognition however, remain incompletely understood. Here, we used electrophysiology and calcium imaging to examine ketamine's impacts on the medial entorhinal cortex and hippocampus, which contain neurons that encode an animal's spatial position, as mice navigated virtual reality and real world environments. Ketamine acutely increased firing rates, degraded cell-pair temporal firing-rate relationships, and altered oscillations, leading to longer-term remapping of spatial representations. In the reciprocally connected hippocampus, the activity of neurons that encode the position of the animal was suppressed after ketamine administration. Together, these findings demonstrate ketamine-induced dysfunction of the MEC-hippocampal circuit at the single cell, local-circuit population, and network levels, connecting previously demonstrated physiological effects of ketamine on spatial cognition to alterations in the spatial navigation circuit.
Keyphrases
- pain management
- single cell
- spinal cord
- mild cognitive impairment
- stem cells
- virtual reality
- rna seq
- major depressive disorder
- bone marrow
- cerebral ischemia
- multiple sclerosis
- functional connectivity
- cognitive impairment
- brain injury
- chronic pain
- cell therapy
- quantum dots
- high throughput
- photodynamic therapy
- high fat diet induced